NASDAQ:ISEE
Delisted
IVERIC bio Inc. Stock News
$39.95
+0 (+0%)
At Close: Oct 09, 2023
IVERIC bio (ISEE) Enters Overbought Territory
07:45am, Wednesday, 14'th Jul 2021
IVERIC bio (ISEE) has moved higher as of late, but there could definitely be trouble on the horizon for this company.
Iveric Bio Raises $100M Via Equity To Fund Zimura Development In Geographic Atrophy
07:17am, Tuesday, 13'th Jul 2021
Iveric bio Inc (NASDAQ: ISEE) priced its underwritten public offering of 11.6 million shares at $8.60 per share, representing a discount of 4.6% from the last close price of $9.01 on Monday. Underwr
IVERIC bio, Inc. Announces Pricing of $100 Million Public Offering of Common Stock
10:09pm, Monday, 12'th Jul 2021
NEW YORK--(BUSINESS WIRE)--Iveric Bio announced the pricing of an underwritten public offering of 11,650,000 shares of its common stock.
IVERIC bio, Inc. Announces Proposed Offering of Common Stock
04:07pm, Monday, 12'th Jul 2021
NEW YORK--(BUSINESS WIRE)--Iveric Bio announced that it is commencing an underwritten public offering of shares of its common stock.
Do Options Traders Know Something About IVERIC bio (ISEE) Stock We Don't?
10:06am, Monday, 12'th Jul 2021
Investors need to pay close attention to IVERIC bio (ISEE) stock based on the movements in the options market lately.
IVERIC bio Stock Increased 11.87%: Why It Happened
05:09pm, Wednesday, 07'th Jul 2021
The stock price of IVERIC bio Inc (NASDAQ: ISEE) increased by 11.87%. This is why it happened.
ISEE Stock Price Increases Over 30% Pre-Market: Why It Happened
07:21am, Tuesday, 06'th Jul 2021
The stock price of IVERIC bio Inc (NASDAQ: ISEE) increased by over 30% pre-market. This is why it happened.
NEW YORK--(BUSINESS WIRE)--Iveric Bio announced that the Company received written agreement from the US FDA under a Special Protocol Assessment (SPA) for the design of GATHER2.
Iveric Bio Reveals Positive Post-Hoc Analyses Of Zimura In Dry Age-Related Macular Degeneration
09:26am, Friday, 18'th Jun 2021
Iveric Bio Inc (NASDAQ: ISEE) has shared the new post-hoc analyses of GATHER1 and the progress of GATHER2 clinical trials evaluating Zimura (avacincaptad pegol) for geographic atrophy (G.A.) second
NEW YORK--(BUSINESS WIRE)--Iveric Bio will present data on Zimura GATHER2 and new GATHER1 post-hoc analyses at its Dry Age-Related Macular Degeneration Virtual Symposium.
Iveric Bio to Host Investor Symposium on Dry Age-Related Macular Degeneration on June 18, 2021
07:30am, Wednesday, 09'th Jun 2021
NEW YORK--(BUSINESS WIRE)--Iveric Bio announced details for its Dry Age-Related Macular Degeneration Virtual Symposium on June 18, 2021, from 10:00 a.m. to 12:00 p.m. ET.
IVERIC bio, Inc. (ISEE) CEO Glenn Sblendorio on Q1 2021 Results - Earnings Call Transcript
03:12pm, Wednesday, 05'th May 2021
IVERIC bio, Inc. (ISEE) CEO Glenn Sblendorio on Q1 2021 Results - Earnings Call Transcript
New Strong Sell Stocks for April 26th
10:31am, Monday, 26'th Apr 2021
ARR, GMDA, ISEE, LMB, and LIQT have been added to the Zacks Rank #5 (Strong Sell) List on April 26, 2021
New Strong Sell Stocks for April 21st
10:31am, Wednesday, 21'st Apr 2021
EXTN, PSXP, ISEE, OR, and QIWI have been added to the Zacks Rank #5 (Strong Sell) List on April 21, 2021
New Strong Sell Stocks for April 6th
12:07pm, Tuesday, 06'th Apr 2021
JOBS, BUD, EURN, ISEE, and KL have been added to the Zacks Rank #5 (Strong Sell) List on April 6, 2021
